EPINEPHRINE
| Brand name | ADRENALIN |
|---|---|
| Active ingredient | EPINEPHRINE |
| Strength | EQ 30MG BASE/30ML (EQ 1MG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | December 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9295657 | March 2035 | use U-1829 |
| 10130592 | March 2035 | product |
| 9119876 | March 2035 | product |
| 12280024 | March 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.